page_banner

Products

(3aR,7aR)-4-(benzo[d]isothiazol-3-yl)octahydrospiro[is indole-2,1-piperazin]-2-ium4-methylbenzenesulfonate. CAS: 1907680-83-4

Short Description:

Catalog Number: XD93390
Cas: 1907680-83-4
Molecular Formula: C26H33N3O3S2
Molecular Weight: 499.68852
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD93390
Product Name (3aR,7aR)-4-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1-piperazin]-2-ium4-methylbenzenesulfonate.
CAS 1907680-83-4
Molecular Formula C26H33N3O3S2
Molecular Weight 499.68852
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

(3aR,7aR)-4-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1-piperazin]-2-ium4-methylbenzenesulfonate, also referred to as the compound BISO, is a chemical compound with a unique structure that lends itself to several potential uses in the field of medicinal chemistry and drug development.One potential application of BISO is in the treatment of neurological disorders. The presence of the benzo[d]isothiazol-3-yl moiety in its structure suggests that BISO may have interactions with specific neurotransmitter systems in the brain, such as the glutamate or GABAergic systems. These neurotransmitter systems are implicated in many neurological disorders like epilepsy, anxiety, and mood disorders. Researchers could explore the potential of BISO to modulate these systems and develop novel therapeutic agents for neurological conditions.Additionally, BISO's spiro[isoindole-2,1-piperazin] core structure has the potential for use in the development of drugs targeting a wide range of biological targets. Its three-dimensional shape and the presence of functional groups can interact with specific receptors or enzymes, allowing for the design of selective and potent pharmaceuticals. Researchers could leverage this structural motif to develop small molecules that target receptors involved in various diseases, such as cancer, cardiovascular disorders, or infectious diseases.Moreover, BISO's spirocyclic structure and charged ammonium group make it a potential candidate for drug delivery systems. The presence of a charged group allows for the formation of ionic complexes with negatively charged molecules, such as nucleic acids or proteins. These complexes can facilitate targeted delivery of bioactive molecules into specific cells or tissues, enhancing therapeutic efficacy while minimizing systemic side effects.It is worth noting that the potential applications of BISO are speculative and require further research and development. Its unique structure presents opportunities for medicinal chemists to explore its pharmacological properties and optimize its potential for drug discovery.As with any chemical compound, the use of BISO should adhere to established safety protocols and guidelines. Researchers should exercise caution during its synthesis, handling, and storage to ensure safety and minimize risks.In conclusion, (3aR,7aR)-4-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1-piperazin]-2-ium4-methylbenzenesulfonate, or BISO, holds promise for various applications in medicinal chemistry and drug development. Its unique structure provides opportunities for the discovery of new therapeutic agents, targeted drug delivery systems, and modulation of neurotransmitter systems. However, extensive research is necessary to fully elucidate its potential and optimize its use in the field of medicine.


  • Previous:
  • Next:

  • Close

    (3aR,7aR)-4-(benzo[d]isothiazol-3-yl)octahydrospiro[is indole-2,1-piperazin]-2-ium4-methylbenzenesulfonate. CAS: 1907680-83-4